Par Drugs & Chemicals Share Price
11 Aug, 2026 3:51 PM (IST)
Par Drugs & Chemicals Performance
- Today's Low
- ₹99
- Today's High
- ₹106
- 52 Week Low
- ₹78
- 52 Week High
- ₹122
- Open Price₹106
- Previous Close₹104
- Volume15,069
- 50 DMA₹95.20
- 100 DMA₹93.90
- 200 DMA₹97.70
Par Drugs & Chemicals Chart
Investment Returns
- Over 1 Month + 12.08%
- Over 3 Month + 6.72%
- Over 6 Month + 3.86%
- Over 1 Year -0.57%
Smart Investing Starts Here Start SIP with Par Drugs & Chemicals for Steady Growth!
Par Drugs & Chemicals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 8.5
- PEG Ratio
- 3.5
- Market Cap Cr
- 124
- P/B Ratio
- 1.1
- Average True Range
- 5.6
- EPS
- 11.8
- Dividend Yield
- 0
- MACD Signal
- 2
- RSI
- 55.64
- MFI
- 70.73
Latest Stock News Updates
In move that will provide relief to home buyers, the Delhi Development Authority has decided to remove separate parking charges from the total flat price in its housing schemes, officials said on Wednesday. According to a recent order, the Delhi Development Authority (DDA) has directed that the total cost of parking construction shall be included in the overall project expenditure. "No separate or additional cost on account of car garage, scooter garage and covered or uncovered parking shall be included in the total cost of the flat," the order states. The total cost of constructing parking spaces will now be included in the total expenditure incurred for the housing pockets to calculate the Plinth Area Rate (PAR) of flats, the order added. The order applies for all ongoing projects, including the DDA Karmayogi Awas Yojana 2025 (FCFS), DDA Towering Heights Karkardooma Housing Scheme 2025 (E-Auction), DDA Nagrik Awas Yojana 2026 (FCFS) and the DDA Towering Heights Karkardooma Housin
- Business Standard
- 5 months 3 weeks ago
MFIN said MFIs' portfolio at risk or PAR level for 31-180 days buckets has improved to 4.1 per cent in Q2FY26 from 4.2 per cent in Q2FY25
- Business Line
- 8 months 1 week ago
Par Drugs & Chemicals Financials
Par Drugs & Chemicals Technicals
EMA & SMA
- Bearish Moving Average 2
- Bullish Moving Average 14
- 20 Day
- ₹98.00
- 50 Day
- ₹95.20
- 100 Day
- ₹93.90
- 200 Day
- ₹97.70
Resistance and Support
- R3 111.10
- R2 108.50
- R1 104.40
- S1 97.80
- S2 95.20
- S3 91.20
Par Drugs & Chemicals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-08-08 | Quarterly Results & Others | To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters |
| 2026-05-14 | Audited Results & Others | To consider other business matters |
| 2026-02-10 | Quarterly Results & Others | To consider other business matters |
| 2025-11-13 | Quarterly Results & Others | To consider other business matters |
| 2025-08-29 | Others | To consider other business matters |
About Par Drugs & Chemicals
Par Drugs & Chemicals primarily engaged in manufacturing of Active Pharma Ingredients and fine chemicals (API) for domestic market as well as for exports to international markets. View More- NSE Symbol
- PAR
- BSE Symbol
- ISIN
- INE04LG01015
Similar Stocks to Par Drugs & Chemicals
Popular Stocks
Par Drugs & Chemicals FAQs
Par Drugs & Chemicals share price is ₹100 As on 12 August, 2026 | 01:01
The Market Cap of Par Drugs & Chemicals is ₹123.5 Cr As on 12 August, 2026 | 01:01
The P/E ratio of Par Drugs & Chemicals is 8.5 As on 12 August, 2026 | 01:01
The PB ratio of Par Drugs & Chemicals is 1.1 As on 12 August, 2026 | 01:01
The 52 week High & Low of Par Drugs & Chemicals is ₹122.4/₹78 respectively As on 12 August, 2026 | 01:01
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.